Stay updated on AVA6000 in Solid Tumours Clinical Trial

Sign up to get notified when there's something new on the AVA6000 in Solid Tumours Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVA6000 in Solid Tumours Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-18T17:49:52.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 with no changes to core study content or page data.
    Difference
    0.0%
    Check dated 2026-03-11T14:00:29.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The study page appears unchanged in core content such as eligibility criteria and locations; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-18T04:08:00.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added details of the Phase 1a 3+3 dose-escalation design for AVA6000 with Q3W and Q2W schedules and the Phase 1b dose expansion with an RDE-1 cohort to identify the optimal biologic dose. It also notes AVA6000 as a FAP-activated doxorubicin and updates the cardiac safety assessment to include cumulative exposure to doxorubicin.
    Difference
    1%
    Check dated 2026-02-11T02:10:06.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding status and NIH CC operations, and updated CMS to version v3.4.1. The previous CMS version v3.4.0 was removed.
    Difference
    0.4%
    Check dated 2026-02-03T23:50:47.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Adds a glossary display and new study-record metadata fields: Last Update Submitted that Met QC Criteria and Last Update Posted, along with No FEAR Act Data and a Revision: v3.4.0 note. Removes older QC-related labels (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4) and, to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T23:58:55.000Z thumbnail image

Stay in the know with updates to AVA6000 in Solid Tumours Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVA6000 in Solid Tumours Clinical Trial page.